School of Medicine

F. Sessions Cole, M.D., has been named assistant vice chancellor for children’s health at the School of Medicine.

School of Medicine investigators have developed a model to identify patients at high risk of developing glaucoma.

School of Medicine researchers found that a malaria drug eased many symptoms of metabolic syndrome in mice. Study findings were published in the November issue of Cell Metabolism, and senior author Clay F. Semenkovich, M.D., professor of medicine and of cell biology and physiology, says funding for a clinical trial has been received.

Investigators at the School of Medicine have developed a model to identify patients at high risk of developing glaucoma. Their research was presented at the annual meeting of the American Academy of Ophthalmology in Las Vegas.

Three Alzheimer’s disease researchers at the School of Medicine in have been named to the 2006 Scientific American 50, an honorary list of the year’s “prime movers” in a variety of scientific disciplines.

ColeF. Sessions Cole, M.D., has been appointed assistant vice chancellor for children’s health at the School of Medicine and chief medical officer at St. Louis Children’s Hospital.

School of Medicine researchers find a potential therapeutic regimen for patients with aggressive neuroendocrine tumors.

Scientists at the School of Medicine will use $14 million in grant funds to establish or expand facilities that provide services needed for research.

A leader in cancer prevention joins Siteman Cancer Center to oversee research, education and community outreach in cancer prevention.

Thomas Ferkol, M.D., has been named director of the Division of Allergy and Pulmonary Medicine in the Department of Pediatrics.